Back to funds

Patient Square Capital LP

hedge fundUpdated 12 days ago

Managed by Patient Square Capital Lp • Latest filing Q3 2026

Portfolio value
$626.7M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$467.1M
Q1 2026$563.6M
Q2 2026$645.5M
Q3 2026$626.7M

Top holdings

23 positions as of Q3 2026

View filing
R

ROIVANT SCIENCES LTD

Value
$282M
Shares
7.71M
% Port
45.00%
R

REVOLUTION MEDICINES INC

Value
$40.2M
Shares
196.0K
% Port
6.42%
U

UNITED THERAPEUTICS CORP DEL

Value
$34M
Shares
62.7K
% Port
5.42%
A

ARGENX SE

Value
$26.8M
Shares
28.0K
% Port
4.28%
P

PHARVARIS N V

Value
$25.7M
Shares
808.6K
% Port
4.09%
A

ABIVAX SA

Value
$24.1M
Shares
243.0K
% Port
3.84%
B

BELITE BIO INC

Value
$22.4M
Shares
131.7K
% Port
3.57%
M

MIRUM PHARMACEUTICALS INC

Value
$20M
Shares
234.0K
% Port
3.19%
Z

ZAI LAB LTD

Value
$15.6M
Shares
591.5K
% Port
2.49%
D

DEFINIUM THERAPEUTICS INC

Value
$14.7M
Shares
385.0K
% Port
2.34%
C

COMPASS PATHWAYS PLC

Value
$13.1M
Shares
1.06M
% Port
2.10%
D

DBV TECHNOLOGIES S A

Value
$13M
Shares
1.11M
% Port
2.07%
B

BEONE MEDICINES LTD

Value
$12.3M
Shares
33.5K
% Port
1.96%
C

COGENT BIOSCIENCES INC

Value
$11.6M
Shares
361.9K
% Port
1.85%
R

ARCUS BIOSCIENCES INC

Value
$10.6M
Shares
410.0K
% Port
1.69%
B

BIONTECH SE

Value
$10.4M
Shares
105.4K
% Port
1.65%
E

ENLIVEN THERAPEUTICS INC

Value
$9.7M
Shares
212.5K
% Port
1.55%
P

VAXCYTE INC

Value
$9.4M
Shares
166.0K
% Port
1.51%
K

KYMERA THERAPEUTICS INC

Value
$9.4M
Shares
84.0K
% Port
1.50%
A

ALLOGENE THERAPEUTICS INC

Value
$7.3M
Shares
4.55M
% Port
1.16%

Explore